The molecular mechanism of peroxisome proliferator action: a model for species differences and mechanistic risk assessment-Reference-Cited by-同舟云学术

The molecular mechanism of peroxisome proliferator action: a model for species differences and mechanistic risk assessment

Published:1992-12 Issue: Volume:64-65 Page:131-139
ISSN:0378-4274
Container-title:Toxicology Letters
language:en
Short-container-title:Toxicology Letters

Author:

Green Stephen,Tugwood Jonathan D.,Issemann Isabelle

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference24 articles.

1. Carcinogenesis by hepatic peroxisome proliferators: Evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans;Reddy;Crit. Rev. Toxicol.,1983

2. Biochemical mechanisms of induction of hepatic peroxisome proliferation;Lock;Ann. Rev. Pharmacol. Toxicol.,1989

3. Peroxisome proliferation and nongenotoxic carcinogenesis: Commentary on a symposium;Moody;Fund. Appl. Toxicol.,1991

4. Nature of the hepatomegalic effect produced by ethyl-chlorophenoxyisobutyrate in the rat;Hess;Nature,1965

5. Mitogenic and carcinogenic effects of a hypolipidemic peroxisome proliferator, [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy 14,643), in rat and mouse liver;Reddy;Cancer Res.,1979

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elucidating hydroxysafflor yellow A's multi-target mechanisms against alcoholic liver disease through integrative pharmacology;Phytomedicine;2024-11

2. Pathogenic mechanisms and regulatory factors involved in alcoholic liver disease;Journal of Translational Medicine;2023-05-04

3. PPARs and pain;British Journal of Pharmacology;2018-06-03

4. PPARs in the central nervous system: roles in neurodegeneration and neuroinflammation;Biological Reviews;2017-02-20

5. The case for intraocular delivery of PPAR agonists in the treatment of diabetic retinopathy;BMC Ophthalmology;2012-09-02